Skip to content

Drug interactions

Nicardipine + Osimertinib

Severity: Minor

Nicardipine and Osimertinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Osimertinib is metabolized partly by CYP3A4, and a weak inhibitor like nicardipine is unlikely to change exposure meaningfully. Clinical impact is expected to be small.

What this interaction means in plain words

Nicardipine and Osimertinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Nicardipine belongs to Cardiovascular; Osimertinib belongs to Oncology.

Evidence level: Low

Why it happens

Nicardipine weakly inhibits CYP3A4, which could slightly reduce osimertinib clearance.

What to do

No dose adjustment is needed; monitor for osimertinib adverse effects including QT prolongation if other risk factors exist.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Nicardipine and Osimertinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Nicardipine with Osimertinib?

MediHelp rates the interaction as minor. Nicardipine and Osimertinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Osimertinib is metabolized partly by CYP3A4, and a weak inhibitor like nicardipine is unlikely to change exposure meaningfully. Clinical impact is expected to be small.

How serious is the interaction between Nicardipine and Osimertinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is needed; monitor for osimertinib adverse effects including QT prolongation if other risk factors exist.

What other medicines interact with Nicardipine?

MediHelp also lists interactions of Nicardipine with, for example, Amifostine, Amlodipine-olmesartan-hydrochlorothiazide, Betrixaban. The full list is on the Nicardipine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in